|Breast implant–associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients|
RN Miranda, TN Aladily, HM Prince, R Kanagal-Shamanna, D De Jong, ...
Journal of clinical oncology 32 (2), 114, 2014
|Bacterial biofilm infection detected in breast implant–associated anaplastic large-cell lymphoma|
H Hu, K Johani, A Almatroudi, K Vickery, B Van Natta, ME Kadin, G Brody, ...
Plastic and reconstructive surgery 137 (6), 1659-1669, 2016
|Mantle cell lymphoma|
CY Cheah, JF Seymour, ML Wang
Journal of clinical oncology 34 (11), 1256-1269, 2016
|Primary testicular lymphoma|
CY Cheah, A Wirth, JF Seymour
Blood, The Journal of the American Society of Hematology 123 (4), 486-493, 2014
|Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes|
CY Cheah, D Chihara, JE Romaguera, NH Fowler, JF Seymour, ...
Annals of Oncology 26 (6), 1175-1179, 2015
|Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib|
CY Cheah, K Burbury, JF Apperley, F Huguet, V Pitini, M Gardembas, ...
Blood, The Journal of the American Society of Hematology 123 (23), 3574-3577, 2014
|Mosunetuzumab induces complete remissions in poor prognosis non-Hodgkin lymphoma patients, including those who are resistant to or relapsing after chimeric antigen receptor Tá…|
SJ Schuster, NL Bartlett, S Assouline, SS Yoon, F Bosch, LH Sehn, ...
Blood, The Journal of the American Society of Hematology 134 (Supplement_1), 6-6, 2019
|Idelalisib in the management of lymphoma|
CY Cheah, NH Fowler
Blood, The Journal of the American Society of Hematology 128 (3), 331-336, 2016
|A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma|
CY Cheah, KE Herbert, K O'rourke, GA Kennedy, A George, PL Fedele, ...
British journal of cancer 111 (6), 1072-1079, 2014
|Primary breast lymphoma|
CY Cheah, BA Campbell, JF Seymour
Cancer treatment reviews 40 (8), 900-908, 2014
|Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network|
CY Cheah, A George, E GinÚ, A Chiappella, HC Kluin-Nelemans, ...
Annals of Oncology 24 (8), 2119-2123, 2013
|Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma|
CY Cheah, LJ Nastoupil, SS Neelapu, SG Forbes, Y Oki, NH Fowler
Blood, The Journal of the American Society of Hematology 125 (21), 3357-3359, 2015
|Rituximab plus hyper‐CVAD alternating with MTX/Ara‐C in patients with newly diagnosed mantle cell lymphoma: 15‐year follow‐up of a phase II study from the MD Anderson Cancer Center|
D Chihara, CY Cheah, JR Westin, LE Fayad, MA Rodriguez, ...
British journal of haematology 172 (1), 80-88, 2016
|Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy|
CY Cheah, MS Hofman, M Dickinson, A Wirth, D Westerman, SJ Harrison, ...
British journal of cancer 109 (2), 312-317, 2013
|Role of the tumor microenvironment in mature B-cell lymphoid malignancies|
NH Fowler, CY Cheah, RD Gascoyne, J Gribben, SS Neelapu, P Ghia, ...
Haematologica 101 (5), 531, 2016
|A clinician's guide to double hit lymphomas|
CY Cheah, Y Oki, JR Westin, F Turturro
British journal of haematology 168 (6), 784-795, 2015
|Encouraging activity for R-CHOP in advanced stage nodular lymphocyte–predominant Hodgkin lymphoma|
MA Fanale, CY Cheah, A Rich, LJ Medeiros, CM Lai, Y Oki, ...
Blood, The Journal of the American Society of Hematology 130 (4), 472-477, 2017
|The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: an international multicenterá…|
TC El-Galaly, D Villa, TY Michaelsen, M Hutchings, NG Mikhaeel, ...
European journal of cancer 75, 195-203, 2017
|Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network|
M Dreyling, HC Kluin-Nelemans, S BeÓ, W Klapper, N Vogt, ...
Leukemia & lymphoma 54 (4), 699-707, 2013
|Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma|
TC El-Galaly, CY Cheah, MD Bendtsen, GS Nowakowski, R Kansara, ...
European Journal of Cancer 93, 57-68, 2018